Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?

According to the WHO, “cirrhosis of the liver” was the 11th leading cause of death globally in 2019. Many kinds of liver diseases can develop into liver cirrhosis, and liver fibrosis is the main pathological presentation of different aetiologies, including toxic damage, viral infection, and metaboli...

Full description

Bibliographic Details
Main Authors: Xinyu Li, Quyan Zhang, Zeyu Wang, Quan Zhuang, Mingyi Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.802251/full
_version_ 1798018273759985664
author Xinyu Li
Xinyu Li
Quyan Zhang
Quyan Zhang
Zeyu Wang
Quan Zhuang
Mingyi Zhao
author_facet Xinyu Li
Xinyu Li
Quyan Zhang
Quyan Zhang
Zeyu Wang
Quan Zhuang
Mingyi Zhao
author_sort Xinyu Li
collection DOAJ
description According to the WHO, “cirrhosis of the liver” was the 11th leading cause of death globally in 2019. Many kinds of liver diseases can develop into liver cirrhosis, and liver fibrosis is the main pathological presentation of different aetiologies, including toxic damage, viral infection, and metabolic and genetic diseases. It is characterized by excessive synthesis and decreased decomposition of extracellular matrix (ECM). Hepatocyte cell death, hepatic stellate cell (HSC) activation, and inflammation are crucial incidences of liver fibrosis. The process of fibrosis is also closely related to metabolic and immune disorders, which are usually induced by the destruction of oxygen homeostasis, including mitochondrial dysfunction, oxidative stress, and hypoxia pathway activation. Mitochondria are important organelles in energy generation and metabolism. Hypoxia-inducible factors (HIFs) are key factors activated when hypoxia occurs. Both are considered essential factors of liver fibrosis. In this review, the authors highlight the impact of oxygen imbalance on metabolism and immunity in liver fibrosis as well as potential novel targets for antifibrotic therapies.
first_indexed 2024-04-11T16:21:19Z
format Article
id doaj.art-9acc4cec13b34ae7bc1ff1032c687d31
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-11T16:21:19Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-9acc4cec13b34ae7bc1ff1032c687d312022-12-22T04:14:21ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-02-01810.3389/fmolb.2021.802251802251Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?Xinyu Li0Xinyu Li1Quyan Zhang2Quyan Zhang3Zeyu Wang4Quan Zhuang5Mingyi Zhao6Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, ChinaXiangya School of Medicine, Central South University, Changsha, ChinaDepartment of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, ChinaXiangya School of Medicine, Central South University, Changsha, ChinaXiangya School of Medicine, Central South University, Changsha, ChinaTransplantation Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, ChinaAccording to the WHO, “cirrhosis of the liver” was the 11th leading cause of death globally in 2019. Many kinds of liver diseases can develop into liver cirrhosis, and liver fibrosis is the main pathological presentation of different aetiologies, including toxic damage, viral infection, and metabolic and genetic diseases. It is characterized by excessive synthesis and decreased decomposition of extracellular matrix (ECM). Hepatocyte cell death, hepatic stellate cell (HSC) activation, and inflammation are crucial incidences of liver fibrosis. The process of fibrosis is also closely related to metabolic and immune disorders, which are usually induced by the destruction of oxygen homeostasis, including mitochondrial dysfunction, oxidative stress, and hypoxia pathway activation. Mitochondria are important organelles in energy generation and metabolism. Hypoxia-inducible factors (HIFs) are key factors activated when hypoxia occurs. Both are considered essential factors of liver fibrosis. In this review, the authors highlight the impact of oxygen imbalance on metabolism and immunity in liver fibrosis as well as potential novel targets for antifibrotic therapies.https://www.frontiersin.org/articles/10.3389/fmolb.2021.802251/fullliver fibrosisoxidative stresshypoxia-inducible factorimmunometabolismmitochondrial dysfunction
spellingShingle Xinyu Li
Xinyu Li
Quyan Zhang
Quyan Zhang
Zeyu Wang
Quan Zhuang
Mingyi Zhao
Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
Frontiers in Molecular Biosciences
liver fibrosis
oxidative stress
hypoxia-inducible factor
immunometabolism
mitochondrial dysfunction
title Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
title_full Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
title_fullStr Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
title_full_unstemmed Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
title_short Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
title_sort immune and metabolic alterations in liver fibrosis a disruption of oxygen homeostasis
topic liver fibrosis
oxidative stress
hypoxia-inducible factor
immunometabolism
mitochondrial dysfunction
url https://www.frontiersin.org/articles/10.3389/fmolb.2021.802251/full
work_keys_str_mv AT xinyuli immuneandmetabolicalterationsinliverfibrosisadisruptionofoxygenhomeostasis
AT xinyuli immuneandmetabolicalterationsinliverfibrosisadisruptionofoxygenhomeostasis
AT quyanzhang immuneandmetabolicalterationsinliverfibrosisadisruptionofoxygenhomeostasis
AT quyanzhang immuneandmetabolicalterationsinliverfibrosisadisruptionofoxygenhomeostasis
AT zeyuwang immuneandmetabolicalterationsinliverfibrosisadisruptionofoxygenhomeostasis
AT quanzhuang immuneandmetabolicalterationsinliverfibrosisadisruptionofoxygenhomeostasis
AT mingyizhao immuneandmetabolicalterationsinliverfibrosisadisruptionofoxygenhomeostasis